ALN-APP

· Alnylam Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ALN-APP, covering 2026-03-31 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy [Phase 2]